Scinai Immunotherapeutics Ltd.
SCNI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001611747
No open-market purchases or sales by Scinai Immunotherapeutics Ltd. insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $49.1K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Scinai Immunotherapeutics Ltd. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 4 | 11 | +7 |
| Shares | 26.9K | 190.0K | +163.1K (+606.4%) |
| Value | $14.9K | $49.1K | +$34.2K (+229.9%) |
New holders (7)
Institutions that held Scinai Immunotherapeutics Ltd. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 62,257 | $15.7K | 0.00% |
| Armistice Capital, LLC | 35,942 | $9.08K | 0.00% |
| Virtu Financial LLC | 19,485 | $5.00K | 0.00% |
| StoneX Group Inc. | 13,092 | $4.56K | 0.00% |
| Captrust Financial Advisors | 12,035 | $3.04K | 0.00% |
| HRT Financial LP | 12,088 | $3.00K | 0.00% |
| Royal Bank of Canada | 815 | $0 | 0.00% |
Sold out (0)
Institutions that held Scinai Immunotherapeutics Ltd. at the end of Q1 2026 and filed for Q2 2026 without it.
None.